Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN - Wikidata - awgldk - TriplyDB

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

http://www.wikidata.org/entity/Q33321821

about

MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN)"Rules of Engagement" of Protein-Glycoconjugate Interactions: A Molecular View Achievable by using NMR Spectroscopy and Molecular Modeling Recent strategies targeting HIV glycans in vaccine design Designing synthetic vaccines for HIV Glycotherapy: new advances inspire a reemergence of glycans in medicine Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain Exchanged A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield Broad neutralization coverage of HIV by multiple highly potent antibodies Microscale electroporation: challenges and perspectives for clinical applications.Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells.Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.A general glycomimetic strategy yields non-carbohydrate inhibitors of DC-SIGN.Effects of neighboring glycans on antibody-carbohydrate interaction.Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds.Synthetic carbohydrate antigens for HIV vaccine design.Rational antibody-based HIV-1 vaccine design: current approaches and future directions Selection of a synthetic glycan oligomer from a library of DNA-templated fragments against DC-SIGN and inhibition of HIV gp120 binding to dendritic cells.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections Multivalent glycocluster design through directed evolution.Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer Convergent assembly and surface modification of multifunctional dendrimers by three consecutive click reactions.High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles.Directed evolution of multivalent glycopeptides tightly recognized by HIV antibody 2G12.Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer Presentation Modality of Glycoconjugates Modulates Dendritic Cell Phenotype.High-mannose glycan-dependent epitopes are frequently targeted in broad neutralizing antibody responses during human immunodeficiency virus type 1 infection.Quinoxalinone Inhibitors of the Lectin DC-SIGN.Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans.Understanding carbohydrate-protein interactions using homologous supramolecular chiral Ru(ii)-glyconanoclusters.Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists.2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.

P2860

Q24647119-914FD2E9-EBCA-4D0F-A7B0-4897567D9230 Q26740050-33612FFA-549B-49A4-AFCE-8B187243325E Q26823603-3154895E-69ED-46D6-861A-FF53DCD6769A Q26862617-B40F5B60-65B3-4F2F-A0B5-0F865CFD09DC Q27027997-887DEC11-EC3F-46DF-80E8-A18DEA5818EF Q27664038-F5833256-BDEB-4B4B-9D9B-E3F8FC5FD2EC Q27664589-BA94824E-E4B8-4F2E-A716-A0BF52DC08F2 Q27675032-75B75FD9-4AA6-4E6B-8531-720433563951 Q29615361-B580CCB6-A753-4178-9247-67021A14F5D2 Q30449429-2D4A1047-35A9-4613-990F-14DDF426B79D Q30531089-D8DBB3C6-7CD7-4548-9B85-CF528E85D73D Q31057778-CE0AB4FB-B79F-466A-A3CC-966888FAFD47 Q33444658-241FB412-1855-47EC-B897-2DE9EFDEDDC8 Q33592001-9B72F108-D495-4C8A-87BF-01C74181F6C9 Q33612459-9AC3EDAF-55CC-4B4F-8CDE-90BE12B747EF Q33625151-84EC043F-7C3E-4E07-8881-77743E9781BD Q33627537-BD4A600F-2E5E-45DC-BC5F-A34C6E8C8CD5 Q33636347-49904E16-2189-4751-B208-E997CEB1C47B Q33662134-7D0EDD0A-98A4-444D-BCC7-8626CC284315 Q33817230-F022EEFF-1F65-4921-A955-EC75BA4DC8C6 Q33840789-50EF0238-8763-41E1-A0E3-20C0F8BB1F88 Q33909079-2E4691F6-B2CA-4D61-9BD6-B086D626BEC2 Q33937285-21D8D172-B4C5-47DD-AADC-ED4CB8EE1480 Q33970022-FD330F45-5CE8-493C-A7ED-2AEBB62A2466 Q33995843-074161AD-05AA-4DDD-A90E-A17DE2902DB8 Q34016211-FFEDB189-4EEA-423B-818E-ECA0AABDCAEF Q34042642-7DE89503-71DD-4EAA-A707-D375D42B84B7 Q34108462-06F091A6-DCF5-46CD-BB72-F4A3EE56B2DF Q34565029-BAB06F80-BAD1-4B68-A09B-26972636FCE2 Q34685535-99DC4B17-F6D8-485E-99C8-2F6CB317F3BD Q34981074-2211C755-68EE-4D83-8BEB-13C8DC8AAB30 Q35124652-C550FB47-2015-46F1-A719-2A9317B92971 Q35753059-761055BF-2790-4F78-B1BD-63062BC93284 Q35801322-CA6F42F6-4D39-4927-A045-37CE13362AA1 Q35826509-BA96F539-2D8B-4C6E-BAC3-8FC290B9B360 Q35983604-1BE3F3EA-B3B1-4F7E-92ED-4B089D380DFE Q36079874-DDE21506-9D85-47AC-B92C-5D30CA38CF10 Q36200887-C21E3BCB-FB62-453A-8378-3B86088185AD Q36431101-33FB4BE7-CDE4-4CB3-A690-CAB8304B19D9 Q36607316-5C4D21C3-7EBB-4611-A4CF-E767BA4D3A4F

P2860

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

http://www.wikidata.org/entity/Q33321821

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Targeting the carbohydrates on ...... onal antibody 2G12 and DC-SIGN

@ast

Targeting the carbohydrates on ...... onal antibody 2G12 and DC-SIGN

@en

Targeting the carbohydrates on ...... nal antibody 2G12 and DC-SIGN.

@nl

type

label

Targeting the carbohydrates on ...... onal antibody 2G12 and DC-SIGN

@ast

Targeting the carbohydrates on ...... onal antibody 2G12 and DC-SIGN

@en

Targeting the carbohydrates on ...... nal antibody 2G12 and DC-SIGN.

@nl

prefLabel

Targeting the carbohydrates on ...... onal antibody 2G12 and DC-SIGN

@ast

Targeting the carbohydrates on ...... onal antibody 2G12 and DC-SIGN

@en

Targeting the carbohydrates on ...... nal antibody 2G12 and DC-SIGN.

@nl

P1433

Q33321821-462D79F8-2B50-47BC-B833-72CC2E8D07FC

P1476

Q33321821-D6F5A0AC-0099-4B48-9C25-A3EEA7896C4D

P2093

Q33321821-89126698-51E8-43E2-94CB-50F550226DC6

Q33321821-B16A1236-4825-4205-8EC0-455F8A166502

Q33321821-B2029DFB-AF33-49FA-916B-658A5C140BF8

Q33321821-CEAF2FD5-C45A-4AA2-98DD-3600F3ED858D

Q33321821-D0741E24-2809-46B4-9A59-DC948842E48D

P2860

Q33321821-0BDDFCD9-1A37-4E54-B1F9-C35A34083DAA

Q33321821-202B09E7-1707-4AA7-90D1-6EB31BEE5732

Q33321821-24ABA3CD-3307-40C0-9564-5DFD9E2F1C9F

Q33321821-2A245A28-E7E5-485E-AD3D-4F56EE93EF75

Q33321821-2A904351-5ACD-4673-AD14-2981B340B61C

Q33321821-2E148098-D4DB-4916-BD35-4D1D8BFC760D

Q33321821-36FA1FD3-6347-4AA3-9478-917F62E77B84

Q33321821-3DB016E1-7B43-42B8-B58F-BF442EFDD812

Q33321821-3E1581A5-BFE0-41A6-8913-D26A7AC2245C

Q33321821-3FEF09D1-EE08-43E7-95B4-40AF2AB9B338

P304

Q33321821-A96DAB10-CE06-4AAD-956A-3873E9EFF923

P31

Q33321821-2B3514D0-1E1A-4051-83F8-84CC7CC9A5C3

P356

Q33321821-174698DE-DCA9-4763-B383-3CB979348F63

P407

Q33321821-AB66A87B-4E7E-4E12-B0B7-7B92DE875D07

P433

Q33321821-765FF69E-9DB4-401E-8481-22B7C35CCE66

P478

Q33321821-BEBF419E-A090-4567-A26B-74950B489AAA

P50

Q33321821-7C84A071-D575-4948-A8B4-16B23C2395BD

Q33321821-D3EC7FD8-1AEE-4544-8260-73C8FEC5516E

P577

Q33321821-97DA1B85-FC5E-4EE0-BC20-EC6A9D939F87

P5875

Q33321821-28EAF217-5BC3-4B0B-A0FD-1D998C26FBE9

P698

Q33321821-44887BBB-DC3E-482B-8C31-A12513F857F4

P921

Q33321821-56C93B32-C361-4396-B6BE-ADCAF36C8CDF

P932

Q33321821-DC34F82C-066D-4E1E-AE4F-76BC86309AC8

P356

PNAS.0712326105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Targeting the carbohydrates on ...... onal antibody 2G12 and DC-SIGN

@en

P2093

Chi-Huey Wong

http://www.w3.org/2001/XMLSchema#string

Dennis R Burton

http://www.w3.org/2001/XMLSchema#string

Rena D Astronomo

http://www.w3.org/2001/XMLSchema#string

Shie-Liang Hsieh

http://www.w3.org/2001/XMLSchema#string

Tsui-Ling Hsu

http://www.w3.org/2001/XMLSchema#string

P2860

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins

Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

DC-SIGN: escape mechanism for pathogens

A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes

Proteins that bind high-mannose sugars of the HIV envelope

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

Peptide and amide bond-containing dendrimers.

P304

3690-3695

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0712326105

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5542721

http://www.w3.org/2001/XMLSchema#string

P698

18310320

http://www.w3.org/2001/XMLSchema#string

P921

P932

2268808

http://www.w3.org/2001/XMLSchema#string